Guanfeng Liang

Title: Guanfeng Liang: Innovator in Pharmaceutical Synthesis

Introduction

Guanfeng Liang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in medicine. With a total of two patents to his name, Liang's work showcases his expertise and innovative approach to chemical synthesis.

Latest Patents

Liang's latest patents include a method of synthesizing diclofenac sodium and a method of synthesizing (1S, 5R)-lactone. The first patent details a comprehensive process for synthesizing diclofenac sodium, a nonsteroidal anti-inflammatory drug. This method involves several steps, including nitration, hydrogenation, amidation, and hydrolysis, achieving an overall yield of up to 67% based on methyl phenylacetate. The second patent presents a method for synthesizing a series of compounds with the structure of (1S, 5R)-lactone. This method utilizes a chiral phosphonic acid catalyst and hydrogen peroxide for enantioselective Baeyer-Villiger oxidation, offering mild reaction conditions and high selectivity, making it suitable for industrial production.

Career Highlights

Guanfeng Liang is affiliated with Fudan University, where he continues to engage in research and development in the field of chemistry. His work has not only advanced the understanding of pharmaceutical synthesis but has also contributed to the development of new methods that can be applied in industrial settings.

Collaborations

Liang collaborates with several colleagues, including Fener Chen and Ge Meng. These partnerships enhance the research environment and foster innovation in their respective fields.

Conclusion

Guanfeng Liang's contributions to pharmaceutical synthesis through his innovative methods highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing chemical processes that can lead to improved medical treatments.